Check out the full study here: https://pmc.ncbi.nlm.nih.gov/articles/PMC11397063/
Diab H, Fuquay T, Datta P, Bickel U, Thompson J, Krutsch K. Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk. Nutrients. 2024 Aug 28;16(17):2886. doi: 10.3390/nu16172886. PMID: 39275201; PMCID: PMC11397063.
What happens when cutting-edge metabolic care meets the realities of breastfeeding? We take a clear-eyed look at a small but important study on semaglutide that found no detectable levels of the medication in breast milk from eight mothers, and we translate the data into practical guidance you can use. Beyond the lab results, we get real about the trade-offs: how appetite suppression can quietly undermine maternal nutrition, milk supply, and infant growth if the plan isn’t carefully managed.
We walk through the study’s methods and why the relative infant dose estimate of 1.26% sits well below commonly accepted safety thresholds, while also calling out the study’s limits: small sample size, only semaglutide tested, and no direct data on higher doses or tirzepatide. Then we zoom out to the bigger picture. Postpartum women managing type 2 diabetes or obesity need tools that stabilize glucose, protect cardiometabolic health, and support sustainable energy—without compromising a baby’s nutritional needs. That balance is possible with intentional choices.
You’ll hear a practical framework for decision-making: consider a lower restart dose, build a tight care team (pediatrician, dietitian, obesity medicine physician, OBGYN or family doctor), monitor infant growth and maternal intake, and track markers like A1C, weight trends, and symptoms of under-fueling. We highlight nutrient priorities for lactation—protein, iron, iodine, choline, DHA, calcium, and overall calories—and we share signs it’s time to adjust the plan, from fatigue and hair loss to decreased milk supply.
The takeaway is nuanced but hopeful. The absence of detectable semaglutide in milk reduces one major concern, yet responsible care still hinges on nutrition, dose, and close monitoring. If you’re navigating GLP-1 therapy while breastfeeding or planning a pregnancy, this conversation equips you to ask sharper questions and collaborate with your clinicians on a plan that protects both mom and baby. If this resonated, subscribe, leave a review, and share the episode with someone who needs a balanced, evidence-informed perspective.
👩🏼⚕️ Live in Missouri? What to be my patient?
Telehealth clinic: https://missourimetabolichealth.com
🥑 Have questions you want answered on the podcast? Email support@missourimetabolichealth.com
✨Freebies✨
Anti-Obesity Medication Options
How To Prevent Diabetes
Healthy Habits Workbook
Preventative Health Checklist
🤗 Socials:
Instagram: https://www.instagram.com/dr.lindsayogle/
TikTok: https://www.tiktok.com/@dr..lindsay.ogle?_t=8prC4VUQZ5i&_r=1
YouTube: https://www.youtube.com/channel/UCMV0X6U0JLZgRMiNwGtmpeg
